Current Edition

Iran Interest
Market Report

Iran Interest

Numerous pharmaceutical companies are considering Iran as a strong site for clinical research. With a huge untapped population, the opportunity to conduct all clinica...
Continue Reading →
Developing a New Branch of Medicine Cell Therapy in Estonia
Market Report

Developing a New Branch of Medicine Cell Therapy in Estonia

A recent announcement from Estonia discussed the launching of the first human stem cell production laboratory in the Baltic States. Behind the lab is a wider initiati...
Continue Reading →
Clinical Trials in Russia – Report on Q3 of 2013
Market Report

Clinical Trials in Russia – Report on Q3 of 2013

The Ministry of Health of the Russian Federation approved 200 new clinical trials of all types during the 3rd quarter of 2013. The main contribution to the total numb...
Continue Reading →
The Role of Regulatory Agencies in New Drug Development: A Global Perspective
Regulatory

The Role of Regulatory Agencies in New Drug Development: A Global Perspective

Regulatory agencies worldwide play a critical role in healthcare as independent reviewers and approvers of applications made by sponsors to conduct clinical trials, a...
Continue Reading →
Risk-based Monitoring: Moving Forward
Regulatory

Risk-based Monitoring: Moving Forward

After issuance of the final guidance document by FDA on Oversight of Clinical Investigations - A Risk-based Approach to Monitoring, the clinical trials industry is em...
Continue Reading →
Regulation for Paediatric Drug Development in India: Need of the Hour
Regulatory

Regulation for Paediatric Drug Development in India: Need of the Hour

India is a popular location for clinical research due to the multitude of benefits it offers, including a large patient pool, low costs and ethical flexibility. Howev...
Continue Reading →